IntraLase Expands Sales with New Hire Gregory Anderson, Vice President, U.S. Sales

"To maximize our U.S. sales opportunity and our share of the U.S.corneal flap market, it was necessary to create a dedicated positionto continue our U.S. sales momentum," said Haffey. "I am gratifiedthat we were able to attract someone of Greg's caliber for thiscritical position. He brings with him a track record of proven successin ophthalmic and surgical equipment sales as well as valuableexpertise in training, marketing and strategic development."

Anderson most recently served as vice president, sales andmarketing, at WaveLight Technologies AG, a German manufacturer ofophthalmic lasers, where he oversaw the successful U.S. introductionof that company's refractive laser platform. Prior to that post, heworked for 16 years at Lumenis Inc./Coherent Medical, an ophthalmicand surgical medical device equipment manufacturer based in SantaClara, Calif., serving most recently as director of North Americansales, where he was responsible for developing the refractive businessunit in the U.S. He has also held a variety of medical and surgicalsales positions at companies such as American V. Mueller and BaxterTravenol Inc. Anderson received a B.S. in marketing from theUniversity of Maryland. "I am delighted to be leading an elite team ofsales professionals to further accelerate the market adoption in theU.S. of our breakthrough technology and procedures," stated Anderson.

About IntraLase Corp.:

IntraLase designs, develops and manufactures an ultra-fast laser,related software and disposable devices used to create a corneal flap,the first step in LASIK surgery for the correction of vision. Thecompany's products improve the safety, precision and visual results ofLASIK procedures by providing a computer-controlled laser solution inplace of the hand-held mechanical, metal-bladed microkeratometraditionally used to create corneal flaps. IntraLase lasers are alsoused in surgical approaches to the treatment of diseased corneas. Thecompany's lasers and disposable per procedure patient interfaces arepresently marketed throughout the United States and 21 othercountries. IntraLase has headquarters and manufactures its products inIrvine. For additional information, visit the company's Web site:www.intralase.com.

Forward-Looking Statements:

Statements contained in this press release that are not historicalinformation are forward-looking statements as defined within thePrivate Securities Litigation Reform Act of 1995. Forward-lookingstatements can be identified by the use of words such as "believe,""expect," "anticipate," "intend," "plan," "estimate," "project," orwords of similar meaning, or future or conditional verbs such as"will," "would," "should," "could," or "may." Such forward-lookingstatements are subject to risks and uncertainties that could causeactual results to differ materially from those projected or implied.Those risks and uncertainties include, but are not limited to: thedegree of continued acceptance of LASIK surgery; potentialcomplications revealed by long-term follow up; the extent of adoptionof our product offering by LASIK surgeons; general economicconditions; changes in federal tax laws governing the ability ofpotential LASIK patients to use pre-tax dollars to pay for LASIKsurgery; the scope of government regulation applicable to ourproducts; patients' willingness to pay for LASIK surgery; our abilityto compete against our competitors; the effectiveness of our measuresto ensure full payment of procedure fees; the occurrence and outcomeof product liability suits against us; our ability to adequatelyprotect our intellectual property; whether we become subject to claimsof infringement or misappropriation of the intellectual propertyrights of others; the continued availability of supplies fromsingle-source suppliers and manufacturers of our key laser components;the ability of our managers, operations, and facilities to manage ourgrowth; the success of our expansion into markets outside the UnitedStates; whether we lose any of our key executives or fail to attractqualified personnel; or if our new products or applications fail tobecome commercially viable.

Certain of these risks and uncertainties, in addition to otherrisks, are more fully described in the company's quarterly report onform 10-Q for the period ending June 30, 2005, as filed with theSecurities and Exchange Commission on Aug. 10, 2005.

These forward-looking statements are made only as of the date ofthis press release, and the company assumes no obligation to update orrevise the forward-looking statements, whether as a result of newinformation, future events, or otherwise.